New analyses of cariprazine studies were presented by Gedeon Richter Plc. at 32e Annual Congress of …
Alkermes Announces Topline Results From Long-Term, Open-Label Safety and Durability of Treatment Effect Study of LYBALVI® (olanzapine and samidorphan)
Alkermes plc (Nasdaq: ALKS) today announced topline results from a phase 3, open-label extension study assessing the …
Announcing 35th Annual Walk for Hope on Sunday, Oct 8
The Foundation of Hope for Research and Treatment of Mental Illness will hold its 35th …
